COSCIENS Biopharma, Inc. (CSCI.TO)
1.96
+0.06
(+3.16%)
CAD |
TSX |
Mar 13, 16:00
COSCIENS Biopharma EPS Diluted (Quarterly) : -0.7884 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arch Biopartners, Inc. | -0.0236 |
| Biocure Technology, Inc. | -0.0029 |
| Microbix Biosystems, Inc. | -0.0084 |
| Theratechnologies, Inc. | -0.1271 |
| Aptose Biosciences, Inc. | -2.764 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.505M |
| Revenue (Quarterly) | 2.042M |
| Total Expenses (Quarterly) | 4.547M |
| Enterprise Value | -2.601M |
| Gross Profit Margin (Quarterly) | 41.87% |
| Profit Margin (Quarterly) | -122.7% |
| Earnings Yield | -338.6% |
| Normalized Earnings Yield | -301.74 |